Physician

Adrienne Callahan, M.D.

According to 2025 Medicare claims, Adrienne Callahan, M.D. (NPI: 1639512551) practices dermatology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is UNIVERSITY HOSPITALS MEDICAL GROUP INC (NPI: 1669499414; TIN: 204881619) and primary practice location at 44145-1503. Callahan is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Callahan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 436 traditional Medicare patients, billed 1,866 HCPCS/CPT codes, and received $69,188 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,029 prescription claims across 304 beneficiaries totaling $1,090,004 in drug costs, led by Tremfya (Guselkumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $45,897 and ending at $69,188. Concurrently, Part D prescription costs have risen steadily, from $27,535 to $1,090,004. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$65K$130K2017 Medicare payment: $45,897 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $129,728 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $89,978 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $82,433 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $86,696 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $52,070 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $76,275 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $69,188 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
20172681,322$45,897
20186433,530$129,728
20195082,361$89,978
20205092,097$82,433
20215382,022$86,696
20223431,424$52,070
20234362,201$76,275
20244361,866$69,188

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$545K$1.1M2017 Drug cost: $27,535 (USD; Tot_Drug_Cst)2018 Drug cost: $475,807 (USD; Tot_Drug_Cst)2019 Drug cost: $349,198 (USD; Tot_Drug_Cst)2020 Drug cost: $306,477 (USD; Tot_Drug_Cst)2021 Drug cost: $457,632 (USD; Tot_Drug_Cst)2022 Drug cost: $541,488 (USD; Tot_Drug_Cst)2023 Drug cost: $1,053,854 (USD; Tot_Drug_Cst)2024 Drug cost: $1,090,004 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017102183$27,535
20183251,075$475,807
2019286866$349,198
20203401,151$306,477
20213541,161$457,632
2022257761$541,488
2023281937$1,053,854
20243041,029$1,090,004

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8299$81
11102Biopsy of related skin growth, first growth6572$57
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more309412$56
17000Destruction of precancer skin growth, 1 growth151191$39
17003Destruction of precancer skin growth, 2-14 growths112627$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TremfyaGuselkumab382,128$513,184
Skyrizi PenRisankizumab-Rzaa131,038$245,462
Taltz AutoinjectorIxekizumab22616$150,916
Dupixent PenDupilumab13350$49,320
AcitretinAcitretin14420$3,695

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Adrienne Callahan, M.D.?

Tedicare shows public-source Medicare data for Adrienne Callahan, M.D. (NPI 1639512551), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adrienne Callahan, M.D. have ACO affiliation data?

Adrienne Callahan, M.D. is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Adrienne Callahan, M.D.?

Adrienne Callahan, M.D. is linked to UNIVERSITY HOSPITALS MEDICAL GROUP INC (billing NPI 1669499414) in the available physician profile data.

Does Adrienne Callahan, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.